Evidence map›Paper›PMID 28467237›Full record

ArticleInternational journal of circumpolar health2017

Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children.

Johan Emdal Navne, Anders Koch, Hans-Christian Slotved, Mikael Andersson, Mads Melbye, Karin Ladefoged, Malene Børresen

Abstract read
In one paragraph

Article in International journal of circumpolar health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Prevalence ofInternational journal of circumpolar health · 2024
    Article
  3. Carriage ofJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Nasopharyngeal Carriage of Methicillin-ResistantInfectious disease reports · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Johan Emdal Navnea Department of Epidemiology Research , Statens Serum Institut , Copenhagen , Denmark.
Anders Kocha Department of Epidemiology Research , Statens Serum Institut , Copenhagen , Denmark.
Hans-Christian Slotvedb Department of Microbiology and Infection Control , Statens Serum Institut , Copenhagen , Denmark.
Mikael Anderssona Department of Epidemiology Research , Statens Serum Institut , Copenhagen , Denmark.
Mads Melbyea Department of Epidemiology Research , Statens Serum Institut , Copenhagen , Denmark.
Karin Ladefogedc Department of Internal Medicine , Queen Ingrids Hospital , Nuuk , Greenland.
Malene Børresena Department of Epidemiology Research , Statens Serum Institut , Copenhagen , Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2010, Greenland introduced the 13-valent pneumococcal conjugate vaccine (Prevnar 13®- PCV-13) in the childhood immunisation program. The authors aimed to evaluate the impact of PCV-13 on nasopharyngeal carriage of bacteria frequently associated with respiratory infections in children.

methodIn 2013 a cross-sectional population-based study of nasopharyngeal carriage was conducted among Greenlandic children aged 0-6 years and results were compared with an equivalent study from 2011. Nasopharyngeal swab samples were tested for Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus. Pneumococcal serotyping was performed by Quellung reaction and serotype-specific antisera. Statistical analysis included logistic regression models, adjusting for known risk factors.

resultA total of 377 nasopharyngeal samples were collected. Overall carriage rate of S. pneumoniae remained unchanged from 2011 to 2013 (51% and 56%, p=0.13), but significant serotype shifts were observed among both vaccinated and unvaccinated children with marked reductions in carriage of vaccine-type pneumococci, counterbalanced by increasing carriage of non-vaccine types. Carriage rate of S. aureus decreased significantly among vaccinated children whereas that of M. catarrhalis increased.

conclusionPCV-13 introduction in Greenland is associated with significant changes in nasopharyngeal bacterial carriage. Continued surveillance is warranted to clarify whether these changes are persistent, and affect the pattern of respiratory and invasive diseases in Greenland.

Indexed as

InuitArctic RegionsCarrier StateChildChild, PreschoolCross-Sectional StudiesFemaleGreenlandHaemophilus influenzaeHumansInfantMaleMoraxella catarrhalisNasopharynxPneumococcal VaccinesRespiratory Tract Infections13-valent pneumococcal vaccinePneumococcal VaccinescarriageInuitPCV-13pneumococcusrespiratory infections

Identifiers

PMID28467237
PMCPMC5497538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.